Impeding the combination of astrocytic ASCT2 and NLRP3 by talniflumate alleviates neuroinflammation in experimental models of Parkinson's disease

Alanine–serine–cysteine transporter 2 (ASCT2) is reported to participate in the progression of tumors and metabolic diseases. It is also considered to play a crucial role in the glutamate-glutamine shuttle of neuroglial network. However, it remains unclear the involvement of ASCT2 in neurological di...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Liu, Ting, Zhou, Yuanzhang, Li, Wenjie, Wang, Min, Song, Nanshan, Zhang, Wenbin, Jiang, Jingwei, Yuan, Shengtao, Ding, Jianhua, Hu, Gang, Lu, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978855/
https://www.ncbi.nlm.nih.gov/pubmed/36873178
http://dx.doi.org/10.1016/j.apsb.2022.07.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978855/
https://www.ncbi.nlm.nih.gov/pubmed/36873178
http://dx.doi.org/10.1016/j.apsb.2022.07.021

Ejemplares similares